Literature DB >> 15104370

High ascitic fluid leptin levels in patients with decompensated liver cirrhosis and sterile ascites: relationship with TNF-alpha levels.

Edoardo Giannini1, Paola Romagnoli, Gian Luca Tenconi, Federica Botta, Federica Malfatti, Bruno Chiarbonello, Mario Mamone, Tommaso Barreca, Roberto Testa.   

Abstract

Leptin is an adipocyte-derived hormone involved in the homeostasis of body composition. An imbalance in leptin regulation has been observed in patients with liver cirrhosis. We aimed to assess serum and ascitic leptin levels in a group of patients with decompensated liver cirrhosis and to evaluate the relationship of these levels with tumor necrosis factor alpha (TNF-alpha). We assessed both serum and ascitic fluid leptin levels in a series of 16 consecutive patients with liver cirrhosis. We calculated the body mass index (BMI) and assessed body fat (BF) of all patients by means of bioelectric impedence analysis. Leptin levels were analyzed in relationship to biochemical indexes, TNF-alpha levels, and body composition. None of the patients had spontaneous bacterial peritonitis. Both serum and ascites leptin levels were correlated with BMI and BF. On average, ascitic fluid leptin levels (13.1 +/- 10.9 ng/ml) were twice as high as serum levels (7.0 +/- 6.4 ng/ml), and the ascitic fluid/serum ratio of leptin was > 1 in all patients. Serum and ascites leptin levels were positively correlated (rS = 0.675, P = 0.009), while no correlation was observed between leptin and TNF-alpha levels, both in serum and in ascites. Serum and ascites TNF-alpha were not correlated. The ascitic fluid leptin levels of cirrhotic patients with sterile ascites are on average two times higher than circulating levels of this hormone. Noteworthily, they correlate significantly with body composition. These findings seem to suggest that in patients with decompensated liver cirrhosis, intraabdominal production of leptin may contribute to the metabolic picture.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15104370     DOI: 10.1023/b:ddas.0000017451.48031.b6

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  36 in total

1.  Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality.

Authors:  M Navasa; A Follo; X Filella; W Jiménez; A Francitorra; R Planas; A Rimola; V Arroyo; J Rodés
Journal:  Hepatology       Date:  1998-05       Impact factor: 17.425

2.  Daily energy and substrate metabolism in patients with cirrhosis.

Authors:  A V Greco; G Mingrone; G Benedetti; E Capristo; P A Tataranni; G Gasbarrini
Journal:  Hepatology       Date:  1998-02       Impact factor: 17.425

3.  Tumour necrosis factor-alpha exerts dual effects on human adipose leptin synthesis and release.

Authors:  H H Zhang; S Kumar; A H Barnett; M C Eggo
Journal:  Mol Cell Endocrinol       Date:  2000-01-25       Impact factor: 4.102

4.  Serum leptin levels in post-hepatitis liver cirrhosis.

Authors:  A V Greco; G Mingrone; A Favuzzi; E Capristo; D Gniuli; G Addolorato; A Brunani; F Cavagnin; G Gasbarrini
Journal:  J Hepatol       Date:  2000-07       Impact factor: 25.083

5.  Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes.

Authors:  T G Kirchgessner; K T Uysal; S M Wiesbrock; M W Marino; G S Hotamisligil
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

6.  Hyperleptinemia in uremic patients undergoing conservative management, peritoneal dialysis, and hemodialysis: A comparative analysis.

Authors:  M P Fontán; A Rodríguez-Carmona; F Cordido; J García-Buela
Journal:  Am J Kidney Dis       Date:  1999-11       Impact factor: 8.860

7.  Correlation of high levels of hyaluronan and cytokines (IL-1beta, IL-6, and TGF-beta) in ascitic fluid of cirrhotic patients.

Authors:  A Sánchez-Rodríguez; M Criado; O Flores; A Olveira-Martín; J A Martín-Oterino; A Esteller
Journal:  Dig Dis Sci       Date:  2000-11       Impact factor: 3.199

8.  Serum leptin concentrations in liver cirrhosis: relationship to the severity of liver dysfunction and their characteristic diurnal profiles.

Authors:  Kana Onodera; Akinobu Kato; Kazuyuki Suzuki
Journal:  Hepatol Res       Date:  2001-11       Impact factor: 4.288

9.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans.

Authors:  R V Considine; M K Sinha; M L Heiman; A Kriauciunas; T W Stephens; M R Nyce; J P Ohannesian; C C Marco; L J McKee; T L Bauer
Journal:  N Engl J Med       Date:  1996-02-01       Impact factor: 91.245

10.  Gender-dependent alterations in serum leptin in alcoholic cirrhosis.

Authors:  A J McCullough; E Bugianesi; G Marchesini; S C Kalhan
Journal:  Gastroenterology       Date:  1998-10       Impact factor: 22.682

View more
  3 in total

1.  Leptin levels in the differential diagnosis between benign and malignant ascites.

Authors:  Mehmet Buyukberber; Mehmet Koruk; M-Cemil Savas; Murat-T Gulsen; Yavuz Pehlivan; Rukiye Deveci; Alper Sevinc; Serdar Gergerlioglu
Journal:  World J Gastroenterol       Date:  2007-01-21       Impact factor: 5.742

Review 2.  Adipokines in Liver Cirrhosis.

Authors:  Christa Buechler; Elisabeth M Haberl; Lisa Rein-Fischboeck; Charalampos Aslanidis
Journal:  Int J Mol Sci       Date:  2017-06-29       Impact factor: 5.923

3.  Immune-Inflammatory and Metabolic Effects of High Dose Furosemide plus Hypertonic Saline Solution (HSS) Treatment in Cirrhotic Subjects with Refractory Ascites.

Authors:  Antonino Tuttolomondo; Domenico Di Raimondo; Chiara Bellia; Giuseppe Clemente; Rosaria Pecoraro; Carlo Maida; Irene Simonetta; Valerio Vassallo; Danilo Di Bona; Eliana Gulotta; Marcello Ciaccio; Antonio Pinto
Journal:  PLoS One       Date:  2016-12-12       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.